Literature DB >> 12693969

Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane.

M Viejo-Díaz1, M T Andrés, J Pérez-Gil, M Sánchez, J F Fierro.   

Abstract

A 31-amino acid synthetic peptide (NH(2)-FFSASCVPGADKGQFPNLCRLCAGTGENKCA-COOH) was chemically synthesized based on the amino acid sequence of a region of human lactoferrin homologous to other sequences present in the N- and C-lobes of all members of the transferrin family proteins. The peptide, termed kaliocin-1, and lactoferrin showed a bactericidal effect in assays performed in low-ionic-strength conditions. This is the first time that it is shown that the antimicrobial effect of lactoferrin depends on the extracellular cation concentration. The antimicrobial effect of kaliocin-1 was lower than that of human lactoferrin, but their activities were inhibited by Na(+) or K(+) in a cation concentration-dependent manner. In addition, the peptide was able to mimic native lactoferrin, inducing K(+)-efflux and a selective dissipation of the transmembrane electrical potential of Escherichia coli cells without causing extensive damage to the outer and inner bacterial membranes. In contrast, the peptide, but not lactoferrin, was able to permeabilize different ions through liposomal membranes. The hypothetical interaction of kaliocin-1 with a bacterial membrane compound is discussed based in the different ion flux induced on cellular and artificial membranes as well as data from circular dichroism assays. Kaliocin-1 was not cytotoxic and could be a suitable model for the design of analogs able to mimic the antibacterial effect of human lactoferrin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12693969     DOI: 10.1023/a:1022657630698

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  8 in total

1.  Antimicrobial mechanism of action of transferrins: selective inhibition of H+-ATPase.

Authors:  María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

Review 2.  Properties and mechanisms of action of naturally occurring antifungal peptides.

Authors:  Nicole L van der Weerden; Mark R Bleackley; Marilyn A Anderson
Journal:  Cell Mol Life Sci       Date:  2013-02-05       Impact factor: 9.261

3.  Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  María T Andrés; Mónica Viejo-Diaz; Francisco Pérez; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.

Authors:  Mónica Viejo-Díaz; María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Antifungal Mechanism of Action of Lactoferrin: Identification of H+-ATPase (P3A-Type) as a New Apoptotic-Cell Membrane Receptor.

Authors:  María T Andrés; Maikel Acosta-Zaldívar; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

6.  Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.

Authors:  L Håversen; N Kondori; L Baltzer; L A Hanson; G T Dolphin; K Dunér; I Mattsby-Baltzer
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

7.  Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity.

Authors:  Mónica Viejo-Díaz; María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

8.  Changes in the hemolytic activity of Candida species by common electrolytes.

Authors:  Lei Wan; Gang Luo; Haibin Lu; Dongying Xuan; Hong Cao; Jincai Zhang
Journal:  BMC Microbiol       Date:  2015-08-22       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.